A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

NCT02283957 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Painful Intermetatarsal Neuroma (Morton's Neuroma)

Interventions

DRUG: CNTX-4975
OTHER: Placebo

Sponsor

Centrexion Therapeutics